Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)

被引:0
|
作者
Karamat, Ayesha [1 ]
O'Neill, Charles [2 ]
Corradetti, Giulia [1 ,3 ]
Lindenberg, Sophiana [1 ]
Tojjar, Jasaman [1 ]
Almidani, Louay [1 ]
Do, Giang [4 ]
Mauger, Stephanie [4 ]
Nittala, Muneeswar [1 ]
Chauhan, Devinder [4 ,5 ]
Sadda, SriniVas [1 ,3 ]
机构
[1] Doheny Eye Inst, Los Angeles, CA USA
[2] Australian Natl Univ, Canberra, ACT, Australia
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Macuject Pty Ltd, Melbourne, Vic, Australia
[5] Vis Eye Inst Ltd, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3726
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Real-world rapid mean visual acuity improvement in patients initiated on aflibercept therapy for treatment-naive neovascular age-related macular degeneration (nAMD)
    Crosby-Nwaobi, Roxanne R.
    Hykin, Philip G.
    Sivaprasad, Sobha
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [3] Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Kiss, Szilard
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Varker, Helen
    Stetsovsky, Diana
    Smith, David
    Garmo, Vincent
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (03): : 253 - 266
  • [4] Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
    Brynskov, Troels
    Munch, Inger Christine
    Larsen, Tobias Malte
    Erngaard, Iiv
    Sorensen, Torben Lykke
    [J]. ACTA OPHTHALMOLOGICA, 2020, 98 (02) : 132 - 138
  • [5] Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials
    Waldstein, Sebastian M.
    Simader, Christian
    Staurenghi, Giovanni
    Chong, N. Victor
    Mitchell, Paul
    Jaffe, Glenn J.
    Lu, Chengxing
    Katz, Todd A.
    Schmidt-Erfurth, Ursula
    [J]. OPHTHALMOLOGY, 2016, 123 (07) : 1521 - 1529
  • [6] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [7] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Ian J Constable
    Ian L McAllister
    Timothy Isaacs
    [J]. International Journal of Ophthalmology, 2011, (01) : 85 - 88
  • [8] Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration
    Citu, Maria Cristina
    Crosby-Nwaobi, Roxanne R.
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Nicholson, Luke
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration
    Chandra, Shruti
    Rasheed, Rajna
    Menon, Deepthy
    Patrao, Namritha
    Lamin, Ali
    Gurudas, Sarega
    Balaskas, Konstantinos
    Pater, Praveen J.
    Ali, Naser
    Sivaprasad, Sobha
    [J]. EYE, 2021, 35 (02) : 409 - 417
  • [10] Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration
    Shruti Chandra
    Rajna Rasheed
    Deepthy Menon
    Namritha Patrao
    Ali Lamin
    Sarega Gurudas
    Konstantinos Balaskas
    Praveen J. Patel
    Naser Ali
    Sobha Sivaprasad
    [J]. Eye, 2021, 35 : 409 - 417